Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced the selection of AMX0318, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist, as a development candidate for ...

Are you a fan of the Fortnite storyline and wondering about all of the live events in the game? Check out our guide breaking ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing ...

Date and Time: January 6, 2026, 8AM ET Webcast: ...

In the elevated anxiety population, NMRA-511 demonstrated a -7.6 and -5.6 placebo-adjusted change from baseline on CMAI total score at Weeks 6 and 8 respectively, representing a Cohen’s d effect size ...

FDA rejects cortisol modulator for hypertension, citing need for additional data despite trial success, delaying approval for Corcept ...

A large cohort study found that statins significantly reduce the risk of death and major cardiovascular events in adults with type 2 diabetes, even among those with low predicted 10-year ...

Olema Pharmaceuticals (OLMA) earns a "Strong Buy" rating, driven by advancing palazestrant for 1st-line ER+/HER2- metastatic breast cancer in pivotal phase 3 trials.

Detailed price information for Medicenna Therapeutics Corp (MDNAF) from The Globe and Mail including charting and trades.

PETERSBURG, Va. — A temporary casino is now scheduled to open January 22, 2026, in Petersburg. The temporary casino is going up on the same 100-acre site off Interstate 95 where Live! Casino & Hotel ...

Aion Medicines Presents Data at ObesityWeek Demonstrating Ultra-long-acting Pharmacokinetics and Pharmacodynamic Effects of AM-710, a Potential Best-in-class GLP-1 Receptor Agonist and the Longest ...